| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/17/2013 | CN103040103A Fennel type snuff |
| 04/17/2013 | CN103040102A Flower odor type snuff |
| 04/17/2013 | CN103040101A Flos sophorae odor type snuff |
| 04/17/2013 | CN103040100A Chamomile odor type snuff |
| 04/17/2013 | CN103040099A Clove type snuff |
| 04/17/2013 | CN103040098A Lavender odor type snuff |
| 04/17/2013 | CN103040097A Apple scent type snuff |
| 04/17/2013 | CN103040096A Jasmine flower scent type snuff |
| 04/17/2013 | CN103040095A Osmanthus scent snuff |
| 04/17/2013 | CN103040094A Gardenia fragrance type snuffs |
| 04/17/2013 | CN103040093A Daffodil-scent snuff |
| 04/17/2013 | CN103040092A Ambergris scent type snuff |
| 04/17/2013 | CN103040091A Folium artemisiae argyi odor type snuff |
| 04/17/2013 | CN103039540A Mosquito repellent incense |
| 04/17/2013 | CN102793683B Slow release composition containing levomilnacipran and preparation method of composition |
| 04/17/2013 | CN102525899B Injection solution of oxiracetam composition and preparation method thereof |
| 04/17/2013 | CN102499906B Rotigotine hydrochloride or free alkali film-forming gel preparation and preparation method thereof |
| 04/17/2013 | CN102397500B Traditional Chinese medicine for treating insomnia, dreamful sleep, amnesia and irritability and improving brain memory |
| 04/17/2013 | CN102397465B Traditional Chinese medicine for treating nanism, activating self growth potential, invigorating brain and increasing intelligence |
| 04/17/2013 | CN102342992B Chinese medicinal composition for treating insomnia and preparation method of preparation thereof |
| 04/17/2013 | CN102329735B Method for preparing curvularin and indolizidine alkaloid and application |
| 04/17/2013 | CN102309438B Midazolam medicament composition as well as preparation method and application thereof |
| 04/17/2013 | CN102283910B Chinese medicinal composition with anti-depression effect and preparation and preparation method thereof |
| 04/17/2013 | CN102233128B Use of p75neurotrophin receptor-extracellular domain (p75NTR-ECD) in medicine for preventing and treating Alzheimer disease |
| 04/17/2013 | CN102138953B Application of chorispora bungeana or extract thereof in preparation of medicaments for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/17/2013 | CN102106825B Solid zopiclone preparation and preparation method thereof |
| 04/17/2013 | CN102106824B Eszopiclone solid preparation and preparation method thereof |
| 04/17/2013 | CN102106806B Method for preparing solid preparation and solid preparation |
| 04/17/2013 | CN102091301B Traditional Chinese medicine composition for soothing nerves and relieving depression and application thereof |
| 04/17/2013 | CN102030744B Iloperidone crystal and preparation method and medicinal composition thereof |
| 04/17/2013 | CN101926929B Traditional Chinese medicine for treating vascular dementia and preparation method thereof |
| 04/17/2013 | CN101912420B Method for preparing pearl powder Chinese medicinal decocting pieces |
| 04/17/2013 | CN101709078B Immune-modulating peptide |
| 04/17/2013 | CN101703622B Preparation method of buccal tablet for improving sleeping |
| 04/17/2013 | CN101678010B A composition comprising (R)-spiro[l- azabicyclo[2.2.2]octane-3,2'(3'h) -furo[2,3 -b]pyridine (azd0328) and its use in the treatment of alzheimer's disease, ADHD or cognitive dysfunction |
| 04/17/2013 | CN101420983B Methods and compositions comprising supramolecular constructs |
| 04/17/2013 | CN101194962B Pill for treating headache and method for preparing the same |
| 04/17/2013 | CN101194922B Acesodyne medicament dropping pills and method for preparing the same |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/16/2013 | US8420811 Tetrahydroisoquinolines and intermediates therefor |
| 04/16/2013 | US8420810 Bicyclic heterocyclic compound |
| 04/16/2013 | US8420775 Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420657 Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors |
| 04/16/2013 | US8420633 Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 04/16/2013 | US8420631 Serotonin receptor antagonist; therapy for obesity, antidepressants, obsessive-compulsive disorders |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420350 Glycosylation-deficient hepatocyte growth factor |
| 04/16/2013 | US8420309 Method of screening compounds using CALHM (FAM26C) |
| 04/16/2013 | US8420112 Solid dosage form for treating headaches |
| 04/16/2013 | US8420106 Extramuscular treatment of traumatic-induced migraine headache |
| 04/16/2013 | CA2712228C 4,5-dihydro-oxazol-2-yl amine derivatives |
| 04/16/2013 | CA2703831C Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/14/2013 | CA2785504A1 Use of inhaled nitrous oxide or xenon to prevent neuropathic pain caused by anti-cancer chemotherapy |
| 04/11/2013 | WO2013052889A1 Nasal delivery mechanism for prophylactic and post-acute use for progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries |
| 04/11/2013 | WO2013052849A2 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | WO2013052787A2 Membrane activated chelators and use in the prevention and treatment of parasitic infection |
| 04/11/2013 | WO2013052727A1 Methods of treatment using modulators of sirt2 |
| 04/11/2013 | WO2013052719A1 Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
| 04/11/2013 | WO2013052700A1 Novel sulfonamides |
| 04/11/2013 | WO2013052575A1 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 04/11/2013 | WO2013051728A1 Agent for improving quality of sleep |
| 04/11/2013 | WO2013051727A1 Agent for improving quality of sleep |
| 04/11/2013 | WO2013051639A1 Pyrazoloquinoline derivative |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013051572A1 Sense-improving agent |
| 04/11/2013 | WO2013051459A1 Promoter capable of promoting inhibition of expression of mrna by rna interference, and use thereof |
| 04/11/2013 | WO2013051266A1 Tau aggregation inhibitor |
| 04/11/2013 | WO2013051159A1 Nop receptor antagonist |
| 04/11/2013 | WO2013050987A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | WO2013050637A1 Oxoisoaporphine nanocapsules for treating depression |
| 04/11/2013 | WO2013050527A1 Quinazoline derivatives as pde10a enzyme inhibitors |
| 04/11/2013 | WO2013050454A1 Ethynyl derivatives as mglur5 allosteric modulators |
| 04/11/2013 | WO2013050424A1 NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF |
| 04/11/2013 | WO2013026852A3 Derivatives of mecamylamine |
| 04/11/2013 | WO2013012811A3 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 04/11/2013 | WO2013012269A3 Method for producing oligodendrocyte precursor cell from pluripotent stem cell |
| 04/11/2013 | WO2013010176A3 Pharmacophores for amyloid fibers involved in alzheimer's disease |
| 04/11/2013 | WO2013006569A3 Herpes virus vaccine and methods of use |
| 04/11/2013 | WO2013006020A3 Composition comprising pyruvic acids for protecting nerve cells |
| 04/11/2013 | WO2012177831A3 Compounds for treating peripheral neuropathies and other neurodegenerative disorders |
| 04/11/2013 | US20130090347 Ethynyl derivatives |
| 04/11/2013 | US20130090341 Heterocyclic compounds |
| 04/11/2013 | US20130090332 Ethynyl derivatives |
| 04/11/2013 | US20130090329 Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature |
| 04/11/2013 | US20130090317 Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries |
| 04/11/2013 | US20130090316 Nasal Delivery Mechanism for Prophylactic and Post-Acute Use of Progesterone and/or its Enantiomer for Use in Treatment of Mild Traumatic Brain Injuries |
| 04/11/2013 | US20130090315 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089618 Linseed Salve |
| 04/11/2013 | US20130089612 R(+)-n-formyl-propargyl-aminoindan |
| 04/11/2013 | US20130089611 Rasagiline citramide |
| 04/11/2013 | US20130089610 R(+)-n-methyl-propargyl-aminoindan |
| 04/11/2013 | US20130089536 Pharmaceutical composition to prevent and treat alzheimer's disease comprising gcp ii mutant |
| 04/11/2013 | CA2851424A1 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | CA2851405A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | CA2851082A1 1,3-substituted azetidine pde10 inhibitors |
| 04/11/2013 | CA2850792A1 Compositions and methods for silencing aldehyde dehydrogenase |